Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss

GLP-1 Medications

Novo Nordisk Sues Hims & Hers to Halt Compounded Wegovy Copycats

The filing escalates a broader U.S. regulatory crackdown on mass‑market compounded GLP‑1 products.

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Novo Nordisk Lowers Wegovy and Ozempic Cash Price to $349 and Unveils $199 Starter Offer

Oval Office Event Pauses as Pharma Representative Faints During Trump’s GLP-1 Pricing Announcement

U.S. Obesity Rate Drops to 37% as GLP-1 Use Surges, Gallup Finds

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Eli Lilly to Raise UK Mounjaro Prices by Up to 170% in September

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research